|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0014898,
umls-concept:C0022116,
umls-concept:C0023216,
umls-concept:C0030705,
umls-concept:C0040044,
umls-concept:C0205360,
umls-concept:C1280500,
umls-concept:C1370123,
umls-concept:C1516240,
umls-concept:C1956346,
umls-concept:C1998793
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1997-3-21
|
|
pubmed:abstractText |
Lower extremity ischaemia is often complicated by coronary artery disease (CAD). Patients with CAD often have impaired fibrinolytic capacity. Plasma plasminogen activator inhibitors (PAI) levels are known to be associated with levels of atherogenic lipids. Purified eicosapentaenoic acid reduces atherogenic lipid levels.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0954-6928
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
837-42
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8993942-Administration, Oral,
pubmed-meshheading:8993942-Adult,
pubmed-meshheading:8993942-Aged,
pubmed-meshheading:8993942-Antigens,
pubmed-meshheading:8993942-Arteriosclerosis Obliterans,
pubmed-meshheading:8993942-Blood Cell Count,
pubmed-meshheading:8993942-Blood Glucose,
pubmed-meshheading:8993942-Coronary Disease,
pubmed-meshheading:8993942-Eicosapentaenoic Acid,
pubmed-meshheading:8993942-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:8993942-Female,
pubmed-meshheading:8993942-Fibrinolysis,
pubmed-meshheading:8993942-Humans,
pubmed-meshheading:8993942-Leg,
pubmed-meshheading:8993942-Lipids,
pubmed-meshheading:8993942-Male,
pubmed-meshheading:8993942-Middle Aged,
pubmed-meshheading:8993942-Plasminogen Inactivators,
pubmed-meshheading:8993942-Platelet Aggregation Inhibitors,
pubmed-meshheading:8993942-Tissue Plasminogen Activator
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Effect of purified eicosapentaenoate ethyl ester on fibrinolytic capacity in patients with stable coronary artery disease and lower extremity ischaemia.
|
|
pubmed:affiliation |
Division of Cardiology, Kumamoto University School of Medicine, Japan.
|
|
pubmed:publicationType |
Journal Article
|
